Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
暂无分享,去创建一个
Constance K Haan | Patrick McBride | Anne L. Taylor | Deborah Grady | Lawrence J Appel | Debra R Judelson | Pamela Ouyang | E. Benjamin | S. Oparil | V. Pinn | K. Schenck-Gustafsson | Sidney C. Smith | L. Appel | M. Oz | L. Mosca | N. Keenan | P. McBride | R. Pasternak | N. Wenger | D. Grady | R. Robertson | B. Walsh | M. Mendelsohn | K. Berra | C. Haan | D. Judelson | P. Ouyang | G. Sopko | N. Chandra-Strobos | S. Hayes | C. Sila | Sidney C Smith | Emelia J Benjamin | Rose Marie Robertson | Lori Mosca | Kathy Berra | Nisha Chandra-Strobos | Rosalind P Fabunmi | Sharonne N Hayes | Nora L Keenan | Suzanne Oparil | Mehmet C Oz | Michael E Mendelsohn | Richard C Pasternak | Vivian W Pinn | Karin Schenck-Gustafsson | Cathy A Sila | George Sopko | Anne L Taylor | Brian W Walsh | Nanette K Wenger | Christine L Williams | R. Fabunmi | Christine L. Williams | P. Mcbride | N. Chandra‐Strobos
[1] W. Millar. Folic acid supplementation. , 2004, Health reports.
[2] J. Herlitz,et al. Similar Risk Reduction of Death of Extended-Release Metoprolol Once Daily and Immediate-Release Metoprolol Twice Daily During 5 Years After Myocardial Infarction , 1999, Cardiovascular Drugs and Therapy.
[3] V. Rastogi,et al. Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4 , 1997, Cardiovascular Drugs and Therapy.
[4] E. Ambrosioni,et al. Clinical aspects of ACE inhibition in patients with acute myocardial infarction , 1996, Cardiovascular Drugs and Therapy.
[5] J. Erikssen,et al. Assessment of physical activity by questionnaire and personal interview with particular reference to fitness and coronary mortality , 2004, European Journal of Applied Physiology and Occupational Physiology.
[6] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[7] S. Yusuf,et al. Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.
[8] C. Hennekens,et al. An update on aspirin in the primary prevention of cardiovascular disease. , 2003, Archives of internal medicine.
[9] K. Fox,et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.
[10] Mary Cushman,et al. Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.
[11] J. Critchley,et al. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.
[12] Tina Costacou,et al. Adherence to a Mediterranean diet and survival in a Greek population. , 2003, The New England journal of medicine.
[13] N J Wald,et al. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.
[14] N. Schneiderman,et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.
[15] A. Zwinderman,et al. Secondary prevention with folic acid: effects on clinical outcomes. , 2003, Journal of the American College of Cardiology.
[16] E. Antman,et al. American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? , 2003, Circulation.
[17] J. Manson,et al. Dietary carotenoids and risk of coronary artery disease in women. , 2003, The American journal of clinical nutrition.
[18] C. Kooperberg,et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. , 2003, JAMA.
[19] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[20] M. Marmot,et al. Leisure time physical activity and disease-specific mortality among men with chronic bronchitis: evidence from the Whitehall study. , 2003, American journal of public health.
[21] P. Bath. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key. , 2003, Stroke.
[22] L Murray,et al. What level of physical activity protects against premature cardiovascular death? The Caerphilly study , 2003, Heart.
[23] J. Manson,et al. Fish and Long-Chain &ohgr;-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women , 2003, Circulation.
[24] E. Rimm,et al. A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. , 2003, The American journal of clinical nutrition.
[25] D. Mozaffarian,et al. Cardiac Benefits of Fish Consumption May Depend on the Type of Fish Meal Consumed: The Cardiovascular Health Study , 2003, Circulation.
[26] J. Shepherd,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial , 2003 .
[27] R. Singh,et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high-risk patients (Indo-Mediterranean diet heart study): a randomized single-blind trial , 2003 .
[28] M. Osler,et al. No inverse association between fish consumption and risk of death from all-causes, and incidence of coronary heart disease in middle-aged, Danish adults. , 2003, Journal of clinical epidemiology.
[29] P. Mehler,et al. Intensive Blood Pressure Control Reduces the Risk of Cardiovascular Events in Patients With Peripheral Arterial Disease and Type 2 Diabetes , 2003, Circulation.
[30] M. Schroll. Physical activity in an ageing population , 2003, Scandinavian journal of medicine & science in sports.
[31] D. Herrington,et al. Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findings. , 2003, Atherosclerosis.
[32] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[33] Lawrence J Appel,et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[34] O. Hess,et al. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. the swiss heart study: a randomized controlled trial☆ , 2003 .
[35] Tiina H Rissanen,et al. Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. , 2003, The Journal of nutrition.
[36] A. Wierzbicki,et al. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. , 2004, Current medical research and opinion.
[37] J. Hsia,et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. , 2002, JAMA.
[38] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[39] G. Tognoni,et al. Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database. , 2002, American heart journal.
[40] Kishore Shetty,et al. Hormone replacement therapy , 2002, BMJ : British Medical Journal.
[41] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[42] T. Meade,et al. Bezafibrate in men with lower extremity arterial disease: randomised controlled trial , 2002, BMJ : British Medical Journal.
[43] D. Pella,et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial , 2002, The Lancet.
[44] S. Yusuf,et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. , 2002, Diabetes care.
[45] D. Graham,et al. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. , 2002, Archives of internal medicine.
[46] M. Santini,et al. Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction. , 2002, The American journal of cardiology.
[47] R. Collins,et al. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review , 2002, The Lancet.
[48] W. Aronow,et al. Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. , 2002, The American journal of cardiology.
[49] Nicholas Smith,et al. Smoking Status and Risk for Recurrent Coronary Events after Myocardial Infarction , 2002, Annals of Internal Medicine.
[50] K. Dickstein,et al. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.
[51] J. Manson,et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. , 2002, The New England journal of medicine.
[52] A. Reunanen,et al. Flavonoid intake and risk of chronic diseases. , 2002, The American journal of clinical nutrition.
[53] O. Hess,et al. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. , 2002, JAMA.
[54] S. Yusuf,et al. Effect of long-term therapy with ramipril in high-risk women. , 2002, Journal of the American College of Cardiology.
[55] E. Benjamin,et al. Task force #1--magnitude of the prevention problem: opportunities and challenges. 33rd Bethesda Conference. , 2002, Journal of the American College of Cardiology.
[56] Deepak L. Bhatt,et al. Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. , 2002, Journal of the American College of Cardiology.
[57] H. Sox,et al. Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease , 2002, Annals of Internal Medicine.
[58] R. Califf,et al. Sertraline treatment of major depression in patients with acute MI or unstable angina , 2002, European Neuropsychopharmacology.
[59] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[60] James F Sallis,et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.
[61] Deborah Grady,et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). , 2002, JAMA.
[62] Jiang He,et al. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. , 2002, The American journal of clinical nutrition.
[63] V. Tikhonoff,et al. Population-based studies improve outcome in hypertensive patients. , 2002, American journal of hypertension.
[64] P. Veugelers,et al. Dietary Iron as a Risk Factor for Myocardial Infarction , 2002, Canadian journal of public health = Revue canadienne de sante publique.
[65] P. Serruys,et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[66] R. Kronmal,et al. Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. , 2002, Archives of internal medicine.
[67] A. Evans,et al. Physical Activity and Coronary Event Incidence in Northern Ireland and France: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) , 2002, Circulation.
[68] A. Hofman,et al. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. , 2002, The American journal of clinical nutrition.
[69] L. Tavazzi,et al. Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002 .
[70] M. Santini,et al. Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002, Circulation.
[71] E. Topol,et al. Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting. , 2002, The American journal of cardiology.
[72] Steven Snapinn,et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.
[73] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[74] L. Goldman,et al. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. , 2002, JAMA.
[75] R. Califf,et al. Underuse of aspirin in a referral population with documented coronary artery disease. , 2002, The American journal of cardiology.
[76] C. Schindler,et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. , 2002, The American journal of medicine.
[77] Deepak L. Bhatt,et al. Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention , 2002, Circulation.
[78] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[79] R. Schall,et al. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy. , 2002, Journal of the American College of Cardiology.
[80] Deepak L. Bhatt,et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. , 2002, Journal of the American College of Cardiology.
[81] A. Coats. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[82] W. Aronow,et al. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. , 2002, The American journal of cardiology.
[83] G. Berglund,et al. Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy. , 2002, Scandinavian journal of public health.
[84] Walter C Willett,et al. Exercise type and intensity in relation to coronary heart disease in men. , 2002, JAMA.
[85] S. Goodman,et al. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. , 2006, The Cochrane database of systematic reviews.
[86] A. Folsom,et al. Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study. , 2001, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[87] E. Bolson,et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. , 2001, The New England journal of medicine.
[88] F. Eberli,et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. , 2001, The New England journal of medicine.
[89] S. Yusuf,et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.
[90] P. Whelton,et al. Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. , 2001, Archives of internal medicine.
[91] A. Go,et al. Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women , 2001, Circulation.
[92] A. Folsom,et al. Dietary catechins in relation to coronary heart disease death among postmenopausal women , 2001, Epidemiology.
[93] J. Anderson,et al. Obesity and disease management: effects of weight loss on comorbid conditions. , 2001, Obesity research.
[94] A. Go,et al. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. , 2001, Journal of the American College of Cardiology.
[95] M. Yu,et al. Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. , 2001, American journal of epidemiology.
[96] C. Viscoli,et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. , 2001, The New England journal of medicine.
[97] B. Cosmi,et al. Ticlopidine versus oral anticoagulation for coronary stenting. , 2001, The Cochrane database of systematic reviews.
[98] V. Fuster,et al. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Circulation.
[99] V. Fuster,et al. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Journal of the American College of Cardiology.
[100] M. Lauer,et al. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis. , 2001, JAMA.
[101] M. Ezekowitz,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.
[102] Jeroen J. Bax,et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. , 2001, European heart journal.
[103] R B D'Agostino,et al. Cardiovascular Risk Assessment Based on US Cohort Studies: Findings From a National Heart, Lung, and Blood Institute Workshop , 2001, Circulation.
[104] K. Schenck-Gustafsson,et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 2001, Circulation.
[105] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[106] F. Grodstein,et al. Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational Study , 2001, Annals of Internal Medicine.
[107] G. Schillaci,et al. [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[108] V. Fuster,et al. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. , 2001, Journal of the American College of Cardiology.
[109] G. Albrektsen,et al. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. , 2001, The American journal of clinical nutrition.
[110] Frank Hu,et al. The Effect of Fruit and Vegetable Intake on Risk for Coronary Heart Disease , 2001, Annals of Internal Medicine.
[111] L. Kalra,et al. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? , 2001, Archives of internal medicine.
[112] T. Lakka,et al. Low Dietary Folate Intake Is Associated With an Excess Incidence of Acute Coronary Events: The Kuopio Ischemic Heart Disease Risk Factor Study , 2001, Circulation.
[113] R. Belardinelli,et al. Exercise training intervention after coronary angioplasty: the ETICA trial. , 2001, Journal of the American College of Cardiology.
[114] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[115] P. O’Connor,et al. Physical inactivity and short-term all-cause mortality in adults with chronic disease. , 2001, Archives of internal medicine.
[116] R. Lees,et al. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. , 2001, The American journal of cardiology.
[117] M. Sclavo. [Physical activity and risk for cardiovascular events in diabetic women]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[118] P. Whelton,et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. , 2001, Archives of internal medicine.
[119] H. Diener,et al. CARDIAC SAFETY IN THE EUROPEAN STROKE PREVENTION STUDY 2 (ESPS2) , 2001, International journal of clinical practice.
[120] M. Biase,et al. Ticlopidine versus aspirin after myocardial infarction (STAMI) trial. , 2001, Journal of the American College of Cardiology.
[121] I-Min Lee,et al. Physical Activity and Coronary Heart Disease in Women: Is No Pain, No Gain Passé? , 2001 .
[122] S. Ebrahim,et al. Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation , 2001, BMJ : British Medical Journal.
[123] J. Hsia,et al. Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS) , 2001, Circulation.
[124] L. Wallentin,et al. Early statin treatment following acute myocardial infarction and 1-year survival. , 2001, JAMA.
[125] S. Ebrahim,et al. Exercise‐based Rehabilitation for Coronary Heart Disease , 2001, The Cochrane database of systematic reviews.
[126] J. Manson,et al. Physical Activity and Risk for Cardiovascular Events in Diabetic Women , 2001, Annals of Internal Medicine.
[127] M. Thun,et al. Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. , 2001, American journal of epidemiology.
[128] G. de Gaetano. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. , 2001, Lancet.
[129] L. Tavazzi,et al. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: Results of GISSI-prevenzione trial , 2001, Lipids.
[130] P. R. R. Ecurrent,et al. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .
[131] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[132] F. Speizer,et al. A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease , 2000, Annals of Internal Medicine.
[133] L. Ramsay,et al. Aspirin for primary prevention , 2000, BMJ : British Medical Journal.
[134] J. Williamson,et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials , 2000, The Lancet.
[135] C. Tudor-Locke,et al. Revisiting the role of physical activity and exercise in the treatment of type 2 diabetes. , 2000, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.
[136] S. Yusuf,et al. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. , 2000, European heart journal.
[137] J. Manson,et al. Triggering of sudden death from cardiac causes by vigorous exertion. , 2000, The New England journal of medicine.
[138] W. Willett,et al. Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in women. , 2000, The American journal of clinical nutrition.
[139] G. Oudit,et al. Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature. , 2000, Canadian family physician Medecin de famille canadien.
[140] K. Teo,et al. Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) , 2000, Circulation.
[141] M. Boaz,et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial , 2000, The Lancet.
[142] D Spiegelman,et al. Prospective study of major dietary patterns and risk of coronary heart disease in men. , 2000, The American journal of clinical nutrition.
[143] S. Cole,et al. Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. , 2000, The American journal of clinical nutrition.
[144] C. Meinert,et al. Gender representation in trials. , 2000, Controlled clinical trials.
[145] A. Nissinen,et al. Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. , 2000, European heart journal.
[146] N. Freemantle,et al. Are beta‐blockers effective in patients who develop heart failure soon after myocardial infarction? A meta‐regression analysis of randomised trials , 2000, European journal of heart failure.
[147] K. Meeter,et al. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. , 2000, Journal of the American College of Cardiology.
[148] R S Paffenbarger,et al. Physical Activity and Coronary Heart Disease in Men: The Harvard Alumni Health Study , 2000, Circulation.
[149] J. Tu,et al. Rate of heart failure and 1-year survival for older people receiving low-dose β-blocker therapy after myocardial infarction , 2000, The Lancet.
[150] Giuseppe Mancia,et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.
[151] Thomas Hedner,et al. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.
[152] K. Alberti,et al. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. , 2000, Archives of internal medicine.
[153] C. Patrono,et al. Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women. , 2000, Epidemiology.
[154] L. García-Rodríguez,et al. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. , 2000, Circulation.
[155] W C Willett,et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. , 2000, The American journal of clinical nutrition.
[156] E. Feskens,et al. Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. , 2000, American journal of epidemiology.
[157] J. Kaprio,et al. Physical activity and other risk factors in male twin-pairs discordant for coronary heart disease. , 2000, Atherosclerosis.
[158] Barry R. Davis,et al. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. , 2000, JAMA.
[159] D. Cook,et al. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. , 2000, Archives of internal medicine.
[160] S. Wannamethee,et al. Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease , 2000, Heart.
[161] R. Gillum,et al. The relation between fish consumption, death from all causes, and incidence of coronary heart disease. the NHANES I Epidemiologic Follow-up Study. , 2000, Journal of clinical epidemiology.
[162] C. Sudlow,et al. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. , 2000, The Cochrane database of systematic reviews.
[163] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[164] C. Mulrow,et al. Pharmacotherapy for hypertension in the elderly , 1998 .
[165] M. Glanz,et al. The Sharer , 2000, Annals of Internal Medicine.
[166] G A Colditz,et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. , 2000, The New England journal of medicine.
[167] W. Newton,et al. Preventing stroke in patients with atrial fibrillation. , 2000, The Journal of family practice.
[168] Illiam,et al. THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .
[169] ichard,et al. FISH CONSUMPTION AND THE 30-YEAR RISK OF FATAL MYOCARDIAL INFARCTION , 2000 .
[170] F. Rank,et al. PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE , 2000 .
[171] J. Manson,et al. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. , 1999, The American journal of clinical nutrition.
[172] S. Tsugane,et al. Alcohol Consumption and All-Cause and Cancer Mortality among Middle-aged Japanese Men: Seven-year Follow-up of the JPHC Study Cohort I , 1999 .
[173] T. Hedner,et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.
[174] R. D'Agostino,et al. Comparison of past versus recent physical activity in the prevention of premature death and coronary artery disease. , 1999, American heart journal.
[175] M. H. Phillips,et al. Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme , 1999, Heart.
[176] O. Benavente,et al. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.
[177] Å. Hjalmarson. Prevention of sudden cardiac death with beta blockers. , 1999, Clinical cardiology.
[178] S. Grundy,et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.
[179] J I Mann,et al. The Oxford Vegetarian Study: an overview. , 1999, The American journal of clinical nutrition.
[180] J. Manson,et al. Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. , 1999, The American journal of clinical nutrition.
[181] G A Colditz,et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. , 1999, The New England journal of medicine.
[182] GISSI-Prevenzione Investigators,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.
[183] Roberto Marchioli,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .
[184] T. Wilt,et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.
[185] W Winkelstein,et al. Work and leisure time physical activity and mortality in men and women from a general population sample. , 1999, Annals of epidemiology.
[186] J. Manson,et al. Dietary protein and risk of ischemic heart disease in women. , 1999, The American journal of clinical nutrition.
[187] D. Waters,et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.
[188] M. de Lorgeril,et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. , 1999, Circulation.
[189] P. Whelton,et al. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[190] M. Ezekowitz,et al. Preventing stroke in patients with atrial fibrillation. , 1999, JAMA.
[191] S. Oparil,et al. Guide to Preventive Cardiology for Women , 1999 .
[192] Eber,et al. Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty , 1999, European journal of clinical investigation.
[193] J. Vestbo,et al. Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction. , 1999, Journal of epidemiology and community health.
[194] M. H. Phillips,et al. Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme , 1999 .
[195] I Vuori,et al. Public health burden of coronary heart disease risk factors among middle-aged and elderly men. , 1999, Preventive medicine.
[196] P. Whelton,et al. Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. , 1999, The New England journal of medicine.
[197] A. Hofman,et al. Dietary iron and risk of myocardial infarction in the Rotterdam Study. , 1999, American journal of epidemiology.
[198] M. Pfeffer,et al. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. , 1999, Journal of the American College of Cardiology.
[199] J. Danesh,et al. Coronary heart disease and iron status: meta-analyses of prospective studies. , 1999, Circulation.
[200] L. Niskanen,et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.
[201] Jean-Louis Martin,et al. Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction Final Report of the Lyon Diet Heart Study , 1999 .
[202] A. Salustri,et al. Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers. , 1999, Giornale italiano di cardiologia.
[203] A. Hofman,et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. , 1999, The American journal of clinical nutrition.
[204] M. Bell,et al. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. , 1999, Circulation.
[205] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[206] J. Manson,et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. , 1999, The American journal of clinical nutrition.
[207] L. Hansson. The Hypertension Optimal Treatment study and the importance of lowering blood pressure. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[208] S. MacMahon,et al. An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. , 1999, Clinical and experimental hypertension.
[209] Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group. , 1999, Hypertension.
[210] S. Tsugane,et al. Alcohol consumption and all-cause and cancer mortality among middle-aged Japanese men: seven-year follow-up of the JPHC study Cohort I. Japan Public Health Center. , 1999, American journal of epidemiology.
[211] H. White,et al. Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow. , 1999, Journal of the American College of Cardiology.
[212] N Freemantle,et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.
[213] S. Oparil,et al. Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement. , 1999, Circulation.
[214] H. Helenius,et al. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT) , 1998, The Lancet.
[215] K. Gould,et al. Intensive lifestyle changes for reversal of coronary heart disease. , 1998, JAMA.
[216] P. Whelton,et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. , 1998, JAMA.
[217] S. Ebrahim,et al. Lifestyle and 15-year survival free of heart attack, stroke, and diabetes in middle-aged British men. , 1998, Archives of internal medicine.
[218] J. Manson,et al. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study , 1998, BMJ.
[219] P Corey,et al. The Impact of Excluding Non‐Leisure Energy Expenditure on the Relation between Physical Activity and Mortality in Women , 1998, Epidemiology.
[220] W. Kannel,et al. Cardiovascular risks of hypertension: lessons from observational studies. , 1998, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[221] Philip D. Harvey,et al. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.
[222] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[223] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[224] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[225] S Hulley,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[226] C. Cannon,et al. Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE registry , 1998 .
[227] B. Magnani,et al. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: Results from the Fosinopril in Acute Myocardial Infarction Study , 1998 .
[228] G. Nante,et al. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. , 1998, The American journal of cardiology.
[229] M. Law,et al. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? , 1998, European Journal of Clinical Nutrition.
[230] G. Boysen,et al. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. , 1998, Archives of internal medicine.
[231] R. Collins,et al. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.
[232] C. Glueck,et al. Prospective assessment of coronary heart disease risk factors: the NHANES I epidemiologic follow-up study (NHEFS) 16-year follow-up. , 1998, Journal of the American College of Nutrition.
[233] S Goya Wannamethee,et al. Changes in physical activity, mortality, and incidence of coronary heart disease in older men , 1998, The Lancet.
[234] A. Gotto,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.
[235] R. Collins,et al. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither , 1998, BMJ.
[236] S. Ripatti,et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. , 1998, Archives of internal medicine.
[237] B. Materson,et al. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients. , 1998, The American journal of cardiology.
[238] B. Magnani,et al. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. , 1998, American heart journal.
[239] D. Hegsted. Dietary fat intake and the risk of coronary heart disease in women. , 1998, The New England journal of medicine.
[240] C. Cannon,et al. Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation. , 1998, Journal of the American College of Cardiology.
[241] E. Barrett-Connor,et al. Hormone replacement therapy, heart disease, and other considerations. , 1998, Annual review of public health.
[242] N. Wintfeld,et al. Postmenopausal hormone therapy and mortality. , 1997, The New England journal of medicine.
[243] Svend Kreiner,et al. Hormone replacement therapy and risk of non-fatal stroke , 1997, The Lancet.
[244] T. Key,et al. Dietary determinants of ischaemic heart disease in health conscious individuals , 1997, Heart.
[245] L. Kuller,et al. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures. , 1997, Archives of internal medicine.
[246] N J Wald,et al. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence , 1997, BMJ.
[247] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[248] A. Kazanjian,et al. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. , 1997, The Canadian journal of cardiology.
[249] N. Wu,et al. Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group. , 1997, Chinese medical journal.
[250] I. Vuori,et al. Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women. , 1997, International journal of epidemiology.
[251] A S Leon,et al. Leisure Time Physical Activity and the 16-Year Risks of Mortality from Coronary Heart Disease and All-Causes in the Multiple Risk Factor Intervention Trial (MRFIT) , 1997, International journal of sports medicine.
[252] R. Senior,et al. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. , 1997, Circulation.
[253] B. Psaty,et al. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women. , 1997, Archives of internal medicine.
[254] J. Feldman,et al. Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. , 1997, BMJ.
[255] K. Malmberg. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.
[256] W C Willett,et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. , 1997, American journal of epidemiology.
[257] SergioCoccheri,et al. Indobufen Versus Warfarin in the Secondary Prevention of Major Vascular Events in Nonrheumatic Atrial Fibrillation , 1997 .
[258] F. Fattapposta,et al. Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. , 1997, Stroke.
[259] A. Dyer,et al. Fish consumption and the 30-year risk of fatal myocardial infarction. , 1997, The New England journal of medicine.
[260] D. Holmes,et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. , 1997, The New England journal of medicine.
[261] B. Psaty,et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.
[262] M. Evans,et al. Body weight and mortality among women. , 1997, Canadian family physician Medecin de famille canadien.
[263] F. Nuttall,et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. , 1997, Archives of internal medicine.
[264] E. O’Brien,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.
[265] Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group. , 1997, Lancet.
[266] A. Zanchetti,et al. Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. , 1997, Journal of hypertension.
[267] R. Singh,et al. Effect of diet and moderate exercise on central obesity and associated disturbances, myocardial infarction and mortality in patients with and without coronary artery disease. , 1996, Journal of the American College of Nutrition.
[268] U. Goldbourt,et al. Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Israeli BIP Study Group. , 1996, The American journal of cardiology.
[269] M. Dennis. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .
[270] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[271] P. Elwood,et al. Dietary magnesium does not predict ischaemic heart disease in the Caerphilly cohort. , 1996, European journal of clinical nutrition.
[272] T. Key,et al. Dietary habits and mortality in 11 000 vegetarians and health conscious people: results of a 17 year follow up , 1996, BMJ.
[273] Salim Yusuf,et al. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials , 1996, BMJ.
[274] J Herlitz,et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. , 1996, European heart journal.
[275] C. Berzuini,et al. Interaction between exercise training and ejection fraction in predicting prognosis after a first myocardial infarction. , 1996, Circulation.
[276] E. Rimm,et al. Relation between Intake of Flavonoids and Risk for Coronary Heart Disease in Male Health Professionals , 1996, Annals of Internal Medicine.
[277] K Steenland,et al. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. , 1996, Circulation.
[278] J. Manson,et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. , 1996, The New England journal of medicine.
[279] T. Harris,et al. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. , 1996, The American journal of clinical nutrition.
[280] E. Rimm,et al. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States , 1996, BMJ.
[281] U. Goldbourt,et al. Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. , 1996, The American journal of cardiology.
[282] B. Fridlund,et al. Long-term effects of a comprehensive rehabilitation programme after myocardial infarction. , 1996, Scandinavian journal of caring sciences.
[283] S. Ebrahim,et al. Cigarette smoking in British men and selection for coronary artery bypass surgery. , 1996, Heart.
[284] A. Folsom,et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. , 1996, The New England journal of medicine.
[285] P. Hamet,et al. Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.
[286] F. Kelly,et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.
[287] Paul Knekt,et al. Flavonoid intake and coronary mortality in Finland: a cohort study , 1996, BMJ.
[288] E. Rimm,et al. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. , 1996, JAMA.
[289] L. Joseph,et al. Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. , 1996, Journal of clinical epidemiology.
[290] PD redaction,et al. Implications of the Diabetes Control and Complications Trial , 1996, Diabetes Care.
[291] S. Genuth. Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus , 1996, Annals of Internal Medicine.
[292] B. Davis,et al. Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. , 1996, Clinical and experimental hypertension.
[293] Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. , 1996, Journal of the American College of Cardiology.
[294] E. Aliot,et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.
[295] H. Hämäläinen,et al. Reduction in sudden deaths and coronary mortality in myocardial infarction patients after rehabilitation. 15 year follow-up study. , 1995, European heart journal.
[296] E. Lonn,et al. Effects of ACE Inhibitors on Mortality When Started in the Early Phase of Myocardial Infarction: Evidence from the Larger Randomized Controlled Trials , 1995, Journal of cardiovascular risk.
[297] A. Reunanen,et al. Body iron stores, dietary iron intake and coronary heart disease mortality , 1995, Journal of internal medicine.
[298] P. Macfarlane,et al. Factors determining case fatality in myocardial infarction "who dies in a heart attack"? , 1995, British heart journal.
[299] T. Sellers,et al. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. , 1995, American journal of public health.
[300] A. Shaper,et al. Weight change and risk of heart attack in middle-aged British men. , 1995, International journal of epidemiology.
[301] J. Manson,et al. Fish consumption and cardiovascular disease in the physicians' health study: a prospective study. , 1995, American journal of epidemiology.
[302] G A Colditz,et al. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. , 1995, Annals of epidemiology.
[303] R. Hoover,et al. EVIDENCE OF A HEALTHY ESTROGEN USER SURVIVOR EFFECT , 1995, Epidemiology.
[304] E. Rimm,et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. , 1995, The New England journal of medicine.
[305] S. Flocke,et al. Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. , 1995, Archives of family medicine.
[306] R. Collins,et al. Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) , 1995, The Lancet.
[307] P. Macfarlane,et al. Risk factors for sudden cardiac death in middle-aged British men. , 1995, Circulation.
[308] M. Levois,et al. Publication bias in the environmental tobacco smoke/coronary heart disease epidemiologic literature. , 1995, Regulatory toxicology and pharmacology : RTP.
[309] C. Glueck,et al. The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. , 1995, Journal of the American College of Nutrition.
[310] B. Magnani,et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .
[311] H. White,et al. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. , 1995, Journal of the American College of Cardiology.
[312] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.
[313] B. Magnani,et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. , 1995, The New England journal of medicine.
[314] Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group. , 1995, European heart journal.
[315] Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. , 1995, The American journal of cardiology.
[316] J. Manson,et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. , 1994, Archives of internal medicine.
[317] L. Wilkins. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.
[318] C. Furberg,et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.
[319] E. Casiglia,et al. Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL). , 1994, Japanese heart journal.
[320] I. Holme,et al. Quality-adjusted meta-analysis of the hypertension/coronary dilemma. , 1994, American journal of hypertension.
[321] P. Deedwania,et al. Effects of Treatment on Outcome in Mildly Symptomatic Patients With Ischemia During Daily Life: The Atenolol Silent Ischemia Study (ASIST) , 1994, Circulation.
[322] David C. Atkins,et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. , 1994, Archives of internal medicine.
[323] K. McPherson,et al. Risk of death from cancer and ischaemic heart disease in meat and non-meat eaters , 1994, BMJ.
[324] A. Reunanen,et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. , 1994, American journal of epidemiology.
[325] P. Touboul,et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.
[326] J M Venäläinen,et al. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. , 1994, The New England journal of medicine.
[327] Stroke Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.
[328] E. Rimm,et al. Dietary iron intake and risk of coronary disease among men. , 1994, Circulation.
[329] R. Krauss,et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). , 1994, Circulation.
[330] A. G. Shaper,et al. Physical activity, hypertension and risk of heart attack in men without evidence of ischaemic heart disease. , 1992, Journal of human hypertension.
[331] A. Hall,et al. ACE-inhibitor therapy after myocardial infarction--a new treatment strategy. , 1994, Zeitschrift fur Kardiologie.
[333] A. Vinik,et al. Implications of the Diabetes Control and Complications Trial , 1993, Diabetes Care.
[334] E. Feskens,et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.
[335] G. Murray,et al. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .
[336] J. Cutler,et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.
[337] J. Gapinski,et al. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. , 1993, Archives of internal medicine.
[338] J. Feldman,et al. Overweight, weight loss, and risk of coronary heart disease in older women. The NHANES I Epidemiologic Follow-up Study. , 1993, American journal of epidemiology.
[339] J. Manson,et al. Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.
[340] E. Rimm,et al. Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.
[341] J. Manson,et al. Intake of trans fatty acids and risk of coronary heart disease among women , 1993, The Lancet.
[342] P. Elwood,et al. Diet and incident ischaemic heart disease: the Caerphilly Study , 1993, British Journal of Nutrition.
[343] R S Paffenbarger,et al. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.
[344] K Rodahl,et al. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. , 1993, The New England journal of medicine.
[345] J. Huttunen,et al. Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population. , 1993, Annals of medicine.
[346] S. Shapiro,et al. A case-control study of myocardial infarction in relation to use of estrogen supplements. , 1993, American journal of epidemiology.
[347] E. Eaker,et al. The risk of acute myocardial infarction after estrogen and estrogen‐progestogen replacement , 1993, British journal of obstetrics and gynaecology.
[348] Caroline S. Fox,et al. Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.
[349] N. Edvardsson,et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris , 1992, The Lancet.
[350] S M Nazarian,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.
[351] K. Swedberg,et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.
[352] J. Sabaté,et al. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. , 1992, Archives of internal medicine.
[353] J. Cutler,et al. Alcohol Use and Mortality from Coronary Heart Disease: The Role of High-Density Lipoprotein Cholesterol , 1992, Annals of Internal Medicine.
[354] B. Fridlund,et al. A supportive–educative caring rehabilitation programme; improvements of physical health after myocardial infarction , 1992 .
[355] C. Isles,et al. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men , 1992, The Lancet.
[356] A. G. Shaper,et al. Physical activity and stroke in British middle aged men. , 1992, BMJ.
[357] S. Roux,et al. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis. , 1992, Journal of the American College of Cardiology.
[358] H. Petrovitch,et al. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group. , 1992, Geriatrics.
[359] C. Eaton. Relation Of Physical Activity And Cardiovascular Fitness To Coronary Heart Disease, Part I: A Meta-Analysis Of The Independent Relation Of Physical Activity And Coronary Heart Disease , 1992, The Journal of the American Board of Family Medicine.
[360] H. Petrovitch,et al. ISOLATED SYSTOLIC HYPERTENSION : LOWERING THE RISK OF STROKE IN OLDER PATIENTS , 1992 .
[361] S. Juul-Möller,et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. , 1992, Lancet.
[362] E. Sonnenblick,et al. Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. , 1992, European heart journal.
[363] J. Cutler,et al. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. , 1992, Annals of internal medicine.
[364] G A Colditz,et al. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. , 2004, Preventive medicine.
[365] L. Wallentin,et al. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden. , 1991, Journal of the American College of Cardiology.
[366] B. Dahlöf,et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) , 1991, The Lancet.
[367] E. Antman,et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. , 1991, Circulation.
[368] R Weatherall,et al. Physical activity and ischaemic heart disease in middle-aged British men. , 1991, British heart journal.
[369] J. Manson,et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.
[370] J. Connett,et al. Physical activity and 10.5 year mortality in the Multiple Risk Factor Intervention Trial (MRFIT). , 1991, International journal of epidemiology.
[371] M Gent,et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.
[372] J. Feldman,et al. Is the Serum Cholesterol‐Coronary Heart Disease Relationship Modified by Activity Level in Older Persons? , 1991, Journal of the American Geriatrics Society.
[373] J. Manson,et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. , 1991, JAMA.
[374] B. Henderson,et al. Decreased Mortality in Users of Estrogen Replacement Therapy , 1991, Archives of internal medicine.
[375] J. Madans,et al. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. , 1991, American journal of obstetrics and gynecology.
[376] G. Colditz,et al. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .
[377] C. Naylor,et al. Aspirin and fibrinolysis in acute myocardial infarction: meta-analytic evidence for synergy. , 1991, Journal of clinical epidemiology.
[378] V. Fuster,et al. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). , 1990, The American journal of cardiology.
[379] J. Manson,et al. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. , 1990, The American journal of medicine.
[380] D. Mirvis,et al. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. , 1990, Archives of internal medicine.
[381] L. Wilkins. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. , 1990, Circulation.
[382] J P Matts,et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.
[383] G A Colditz,et al. A meta-analysis of physical activity in the prevention of coronary heart disease. , 1990, American journal of epidemiology.
[384] L H Kuller,et al. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). , 1990, American journal of public health.
[385] J. Boissel,et al. Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol. , 1990, The American journal of cardiology.
[386] C. Cimminiello,et al. Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. , 1990, Circulation.
[387] D. Beevers,et al. A meta-analysis of mortality and coronary prevention in hypertensive patients treated with beta-receptor blockers. , 1990, Journal of human hypertension.
[388] J. Morris,et al. Exercise in leisure time: coronary attack and death rates. , 1990, British heart journal.
[390] W. Miall. β‐Blockers vs. Thiazides in the Treatment of Hypertension: A Review of the Experience of the Large National Trials , 1990, Journal of cardiovascular pharmacology.
[391] B. Henderson,et al. Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.
[392] M. Bobbio. Does post myocardial infarction rehabilitation prolong survival? A meta-analytic survey. , 1989, Giornale italiano di cardiologia.
[393] P. Leren. Prevention of coronary heart disease: some results from the Oslo secondary and primary intervention studies. , 1989, Journal of the American College of Nutrition.
[394] P. Elwood,et al. EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.
[395] W. L. Ooi,et al. Treatment-induced blood pressure reduction and the risk of myocardial infarction. , 1989, JAMA.
[396] V. Hawthorne,et al. Passive smoking and cardiorespiratory health in a general population in the west of Scotland. , 1989, BMJ.
[397] J. Buring,et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. , 1989, Circulation.
[398] T. Meade,et al. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. , 1989, Journal of epidemiology and community health.
[399] J. Stamler,et al. DIETARY CHOLESTEROL AND ISCHAEMIC HEART DISEASE , 1989, The Lancet.
[400] Palle Petersen,et al. PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.
[401] L. Gatewood,et al. Test of Effect of Lipid Lowering by Diet on Cardiovascular Risk: The Minnesota Coronary Survey , 1989, Arteriosclerosis.
[402] Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.
[403] Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.
[404] R. Kronmal,et al. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. , 1988, The New England journal of medicine.
[405] E. Barrett-Connor,et al. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. , 1988, American journal of epidemiology.
[406] B. Butland,et al. Heart disease in British vegetarians. , 1988, The American journal of clinical nutrition.
[407] G. Guyatt,et al. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. , 1988 .
[408] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[409] C. Bulpitt,et al. The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). , 1988, Journal of human hypertension.
[410] D. Reed,et al. Physical activity and coronary heart disease in middle-aged and elderly men: the Honolulu Heart Program. , 1988, American journal of public health.
[411] E. Chee,et al. Heart disease mortality in nonsmokers living with smokers. , 1988, American journal of epidemiology.
[412] E. Weber. Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.
[413] J. Tuomilehto,et al. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. , 1988, JAMA.
[414] R. Rauramaa,et al. Leisure time and occupational physical activity: risk of death from ischemic heart disease. , 1988, American journal of epidemiology.
[415] The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group. , 1988, European heart journal.
[416] C. Dollery,et al. The Medical Research Council Hypertension Trial: the smoking patient. , 1988, American Heart Journal.
[417] I. Wiklund,et al. Morbidity and quality of life 5 years after early intervention with metoprolol in suspected acute myocardial infarction. , 1988, Cardiology.
[418] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[419] A S Leon,et al. Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial. , 1987, JAMA.
[420] L. Kuller,et al. Effects of passive smoking in the Multiple Risk Factor Intervention Trial. , 1987, American journal of epidemiology.
[421] J. Tuomilehto,et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. , 1987, Journal of hypertension.
[422] S. Sidney,et al. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. , 1987, Obstetrics and gynecology.
[423] P. Sleight. Beta blockade early in acute myocardial infarction. , 1987, The American journal of cardiology.
[424] E. Barrett-Connor,et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.
[425] E. O'Brien,et al. Treatment of Elderly Hypertensives: Results and Implications of Recent Trials , 1987, Journal of Cardiovascular Pharmacology.
[426] J. Willerson,et al. The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group. , 1987, European heart journal.
[427] I. Bosaeus,et al. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. , 1986, The American journal of clinical nutrition.
[428] C. Bengtsson,et al. Socioeconomic factors and physical activity in relation to cardiovascular disease and death. A 12 year follow up of participants in a population study of women in Gothenburg, Sweden. , 1986, British heart journal.
[429] J. Stamler,et al. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. , 1986, Journal of the American College of Cardiology.
[430] G. Wagner. Summary of Short‐ and Long‐Term Studies with Bisoprolol in Coronary Heart Disease (CHD) , 1985, Journal of cardiovascular pharmacology.
[431] Lewis Hd. Unstable angina: status of aspirin and other forms of therapy. , 1985 .
[432] D. Sackett,et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.
[433] P. Wilson,et al. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. , 1985, The New England journal of medicine.
[434] S. Marra,et al. Long-term follow-up after a controlled randomized post-myocardial infarction rehabilitation programme: effects on morbidity and mortality. , 1985, European heart journal.
[435] D Kromhout,et al. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.
[436] R. Lew,et al. Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. , 1985, The New England journal of medicine.
[437] G. Cran,et al. Very early intervention with metoprolol in suspected acute myocardial infarction. , 1985, European heart journal.
[438] H. Lewis. Unstable angina: status of aspirin and other forms of therapy. , 1985, Circulation.
[439] C. Bengtsson,et al. Morbidity and mortality in relation to blood pressure and antihypertensive treatment. A 12-year follow-up study of a population sample of Swedish women. , 2009, Acta medica Scandinavica.
[440] M. LeWinter,et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.
[441] D. Durrer,et al. Effects of cardiac rehabilitation after myocardial infarction: changes in coronary risk factors and long-term prognosis. , 1983, American heart journal.
[442] S. Johansson,et al. Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. , 1983, British heart journal.
[443] I. Lukšić,et al. Cardiac Rehabilitation after Acute Myocardial Infarction , 1983 .
[444] R. Shephard,et al. Relation of exercise to the recurrence rate of myocardial infarction in men. Ontario Exercise-Heart Collaborative Study. , 1983, The American journal of cardiology.
[445] A multicenter study on timolol in secondary prevention after myocardial infarction. , 1983, Acta medica Scandinavica. Supplementum.
[446] I. Lukšić,et al. Cardiac rehabilitation after acute myocardial infarction. 9-year controlled follow-up study. , 1983, Cardiology.
[447] M. Neophytou,et al. Exercise after Myocardial Infarction: A Controlled Trial , 1982, Journal of the Royal College of Physicians of London.
[448] J. Lewis,et al. Confidence in results of beta-blocker postinfarction trials. , 1982, British medical journal.
[449] R. Prescott,et al. CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.
[450] J. Salonen,et al. Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. , 1982, American journal of epidemiology.
[451] A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. , 1982, The New England journal of medicine.
[452] A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. , 1982, JAMA.
[453] K. Swedberg,et al. EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.
[454] C. A. Gilbert,et al. Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction: The National Exercise and Heart Disease Project∗☆ , 1981 .
[455] K. Breddin,et al. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group. , 1980, Circulation.
[456] G. Rosenhamer,et al. Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease. , 1980, Atherosclerosis.
[457] Lippincott Williams Wilkins,et al. Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. , 1980, Circulation.
[458] F. Gyntelberg,et al. Physical fitness and risk of myocardial infarction in Copenhagen males aged 40-59: a five- and seven-year follow-up study. , 1980, Scandinavian journal of work, environment & health.
[459] R. Peto,et al. EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Report of a Randomised Trial , 1980, The Lancet.
[460] The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group. , 1980, Circulation.
[461] P. Elwood,et al. ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.
[462] H. Hämäläinen,et al. REDUCTION IN SUDDEN DEATHS BY A MULTIFACTORIAL INTERVENTION PROGRAMME AFTER ACUTE MYOCARDIAL INFARCTION , 1979, The Lancet.
[463] E. Beckman,et al. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. , 1979, Obstetrics and gynecology.
[464] K Uberla,et al. Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo , 1979, Thrombosis and Haemostasis.
[465] P. Sorlie,et al. Relation of lipids, weight and physical activity to incidence of coronary heart disease: the Puerto Rico heart study. , 1978, The American journal of cardiology.
[466] D. Grafnetter,et al. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. , 1978, British heart journal.
[467] J. Naughton. The National Exercise and Heart Disease Project , 1978 .
[468] The coronary drug project aspirin study. Implications for clinical care. Coronary Drug Project Research Group. , 1978, Primary care.
[469] W. Martin,et al. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. , 1978, Journal of chronic diseases.
[470] C. Mcgilchrist,et al. Low fat, low cholesterol diet in secondary prevention of coronary heart disease. , 1978, Advances in experimental medicine and biology.
[471] J. Stamler. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin. , 1977, Advances in experimental medicine and biology.
[472] H. Jick,et al. Myocardial infarction and estrogen therapy in post-menopausal women. , 1976, The New England journal of medicine.
[473] J. Hakkila. Morbidity and mortality after myocardial infarction. , 1976, Bibliotheca cardiologica.
[474] A. Multicentre. Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. , 1975, British medical journal.
[475] E. C. Hammond,et al. Aspirin and coronary heart disease: findings of a prospective study. , 1975, British medical journal.
[476] C. Seltzer. Smoking and coronary heart disease in the elderly , 1975, The American journal of the medical sciences.
[477] J. Stamler. Clofibrate and niacin in coronary heart disease. , 1975, JAMA.
[478] W. Kannel,et al. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. , 1974, Lancet.
[479] P C Elwood,et al. A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction , 1974, British medical journal.
[480] The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. , 1973, JAMA.